Targeting of CD40 and PD-L1 Pathways Inhibits Progression of Oral Premalignant Lesions in a Carcinogen-induced Model of Oral Squamous Cell Carcinoma.
Monteiro de Oliveira Novaes JA, Hirz T, Guijarro I, Nilsson M, Pisegna MA, Poteete A, Barsoumian HB, Fradette JJ, Chen LN, Gibbons DL, Tian X, Wang J, Myers JN, McArthur MJ, Bell D, William WN Jr, Heymach JV.
Monteiro de Oliveira Novaes JA, et al. Among authors: mcarthur mj.
Cancer Prev Res (Phila). 2021 Mar;14(3):313-324. doi: 10.1158/1940-6207.CAPR-20-0418. Epub 2020 Dec 4.
Cancer Prev Res (Phila). 2021.
PMID: 33277316